Percentage of episodes with an International Normalized Ratio (INR) test performed three to seven days after a newly started interacting anti-infective medication for individuals receiving warfarin
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Number of episodes in the denominator with an INR test performed three to seven days after the start date of an anti-infective medication
-
1.15 Denominator
Number of episodes with a newly started interacting anti-infective medication with an overlapping days’ supply of warfarin.
-
Exclusions
We excluded the following individuals from the denominator:
• Individuals with a diagnosis of cancer
• Individuals who are monitoring INR at home
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Patient Safety Spring Cycle 2019Initial EndorsementLast UpdatedRemoval Date
-
StewardCenters for Medicare & Medicaid ServicesSteward Organization POC EmailSteward Organization Copyright
Limited proprietary coding is contained in the measure specifications for user convenience. Use of these codes may require permission from the code owner or agreement to a license.
ICD-10 codes are copyright © World Health Organization (WHO), Fourth Edition, 2010. CPT © 2010 American Medical Association. CPT is a registered trademark of the American Medical Association. All rights reserved
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-